“…To detect the bone matrix distribution, angiogenesis, and osteoclasts and osteoblasts in the new bone, we analyzed the expression of cell‐specific biomarkers in these tissues. OPN, OCN, RUNX2, and TRAP positivity were evaluated based on the number of cells exhibiting strong immunolabeling of the cell membrane and/or cytoplasm according to the previous studies (Hawthorne et al, ; Karsenty, Kronenberg, & Settembre, ; Kern, Shen, Starbuck, & Karsenty, ; Komori et al, ; Oryan et al, ; Pereira et al, ; Wang et al, ). VEGF expression was assessed based on the number of cells bordering new vessels as previously described (Soini et al, ).…”